STC
SGMO

SEI Trust Company’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

SEI Trust Company’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$369K Sell
34,209
-1,200
-3% -$15.7K ﹤0.01% 1185
2014
Q2 		$541K Sell
35,409
-26,581
-43% -$382K 0.01% 1089
2014
Q1 		$1.12M Buy
+61,990
New +$1.19M 0.01% 875

Other funds holding SGMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

SEI Trust Company's SGMO Position: Q3 2014 in Review

SEI Trust Company reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 3.4% in Q3 2014, selling an estimated $15.7K and leaving 34,209 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #1185.

SEI Trust Company first reported a position in SGMO in Q1 2014 and has held it in 3 quarters since. The position peaked at $1.12M in Q1 2014. 157 funds tracked by Wall St. Rank hold SGMO as of Q3 2014.

  • SEI Trust Company held 34,209 shares of SANGAMO THERAPEUTICS INC worth $369K as of Q3 2014.
  • SEI Trust Company sold 1,200 SANGAMO THERAPEUTICS INC shares in Q3 2014, an estimated $15.7K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of SEI Trust Company's portfolio in Q3 2014, its #1185 holding.
  • SEI Trust Company first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and has held it in 3 quarters since.
  • SEI Trust Company's SANGAMO THERAPEUTICS INC position peaked at $1.12M in Q1 2014.
  • 157 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.